U-IPHA

Q:IPHA - INNATE PHARMA SPON ADS EACH REP 1 ORD SHS - Website unknown - click to update

18:47:17 EDT

Sym-X	Bid - Ask					Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
IPHA - Q	0.2	1.16	·	3.01	1.0	2.90	+0.07	2.5	9.1	24	29	2.91 2.93 2.83	4.52 1.90	16:00:05	May 26	15 min RT 2¢

Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
Nasdaq Indicators -- Market: Nasdaq -- Bid Tick: Down -- UPC Restricted: No

Fundamentals · Holders · Trade Workstation · Market Depth · 3 Month Closes · Technical Charts 1 yr | 2 yr | 3 yr | 5 yr | 10 yr | 15 yr | 20 yr · Live Charts 1 yr | 1 day · 1yr Bulletins · Historical · Options · Portfolio

Recent Trades - Last 10 of 29

More trades...

Time ET	Ex	Price	Change	Volume
16:00:05	Q	2.90	0.07	1
16:00:05	Q	2.90	0.07	1
16:00:05	Q	2.90	0.07	1
16:00:05	Q	2.90	0.07	1
15:59:51	Q	2.90	0.07	100
15:59:51	Q	2.90	0.07	100
15:59:40	Q	2.89	0.06	93
15:57:50	Q	2.86	0.03	2
15:57:39	Q	2.90	0.07	300
15:55:01	Q	2.93	0.10	100

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Date ET	Symbol	Type	Headline
2023-05-26 01:00	U:IPHA	News Release200	Innate Pharma Highlights Phase 1/2 Dose Escalation Safety and Preliminary Efficacy of Sanofi Developed First NK Cell Engager SAR ¢ € ™579 / IPH6101 in R/R AML
2023-05-23 01:00	U:IPHA	News Release200	Innate Pharma to Participate in Upcoming Investor Conferences
2023-05-15 01:00	U:IPHA	News Release200	Innate Pharma to Present IPH6501 Preclinical Data at The EHA 2023 Congress
2023-05-12 16:00	U:IPHA	News Release200	Outcome of Innate Pharma ¢ € ™s 2023 Annual General Meeting
2023-05-10 01:00	U:IPHA	News Release200	Innate Pharma Reports First Quarter 2023 Financial Results and Business Update
2023-05-09 01:00	U:IPHA	News Release200	Number of shares and voting rights of Innate Pharma as of May 1, 2023

Date ET

Symbol

Type

Headline

2023-05-26 01:00

U:IPHA

News Release

Innate Pharma Highlights Phase 1/2 Dose Escalation Safety and Preliminary Efficacy of Sanofi Developed First NK Cell Engager SAR ¢ € ™579 / IPH6101 in R/R AML

2023-05-23 01:00

U:IPHA

News Release

Innate Pharma to Participate in Upcoming Investor Conferences